Citation Impact
Citing Papers
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
DAF-16/FOXO and HLH-30/TFEB function as combinatorial transcription factors to promote stress resistance and longevity
2018 StandoutNobel
Burn wound healing and treatment: review and advancements
2015 Standout
Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
2012
DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic
2012
Comparative efficacies of different antibiotic treatments to eradicate nontypeable Haemophilus influenzaeinfection
2008 StandoutNobel
Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy
2011
Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant <em>Enterobacteriaceae</em>
2018
Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review
2019 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Molecular mechanisms of antibiotic resistance
2014 Standout
Subtherapeutic Initial β-Lactam Concentrations in Select Critically Ill Patients
2011
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
The genetics of ageing
2010 StandoutNature
Pseudomonas Aeruginosa: Resistance to the Max
2011 Standout
Optimization of meropenem dosage in the critically ill population based on renal function
2010
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics*
2009
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Loss of Topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis
2010
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
2010
Diurnal oscillations of endogenous H2O2 sustained by p66Shc regulate circadian clocks
2019
The Science of Antibiotic Discovery
2020 Standout
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Molecular chaperones in protein folding and proteostasis
2011 StandoutNature
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
2011 Standout
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
2009
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Acute respiratory distress syndrome
2019 Standout
Prevention of Venous Thromboembolism
2004 Standout
Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia*
2008
Unique features of long non-coding RNA biogenesis and function
2015 Standout
Autophagy and Aging
2011 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Tackling antibiotic resistance: the environmental framework
2015 Standout
The effects of genistein and daidzein on cell proliferation kinetics in HT29 colon cancer cells: the expression of CTNNBIP1 (β-catenin), APC (adenomatous polyposis coli) and BIRC5 (survivin)
2014
Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment
2015
Efflux-Mediated Drug Resistance in Bacteria
2009
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
A ncRNA Modulates Histone Modification and mRNA Induction in the Yeast GAL Gene Cluster
2008
The Hallmarks of Aging
2013 Standout
Pharmacokinetic issues for antibiotics in the critically ill patient
2009
Improving antibiotic dosing in special situations in the ICU
2012
NAD+ metabolite levels as a function of vitamins and calorie restriction: evidence for different mechanisms of longevity
2010
Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa
2007
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
Long noncoding RNAs: functional surprises from the RNA world
2009 Standout
Lumacaftor/Ivacaftor: A Review in Cystic Fibrosis
2016
Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
2015
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
2009
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008)
2009
Multidrug efflux pumps: structure, function and regulation
2018 Standout
Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. A Meta-analysis of Individual Patient Data from Randomized Trials
2016
Treatment of drug-resistant pneumococcal pneumonia
2002
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
NF-κB in Aging and Disease.
2011 Standout
β‐L actam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review
2012
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
2004
Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
2012
Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients
2010
LC Method for the Determination of Meropenem in Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring
2009
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
2007
Disease Tolerance as a Defense Strategy
2012 StandoutScience
The cytotoxic and genotoxic effects of daidzein on MIA PaCa-2 human pancreatic carcinoma cells and HT-29 human colon cancer cells
2018
Three Decades of β-Lactamase Inhibitors
2010 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Deep vein thrombosis: prophylaxis in acute spinal cord injured patients.
1988
Natural product and natural product derived drugs in clinical trials
2014 Standout
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota
2017 Standout
Therapeutic drug monitoring of antimicrobials
2011
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
Synthetic Riboswitches That Induce Gene Expression in Diverse Bacterial Species
2010 StandoutNobel
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
Origins and Evolution of Antibiotic Resistance
2010 Standout
How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients
2018
Flavonoids in Cancer and Apoptosis
2018 Standout
Clinical practice guideline: Adult sinusitis
2007 Standout
Evolutionary Comparison of the Mechanism of DNA Cleavage with Respect to Immune Diversity and Genomic Instability
2012 StandoutNobel
Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
2012
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
In Vivo Efficacy of Meropenem with a Novel Non-β-Lactam–β-Lactamase Inhibitor, Nacubactam, against Gram-Negative Organisms Exhibiting Various Resistance Mechanisms in a Murine Complicated Urinary Tract Infection Model
2018
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Pervasive transcription constitutes a new level of eukaryotic genome regulation
2009
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Works of Chonghua Li being referenced
Genistein and daidzein effects on proliferation, cell membranes, cell cycles and cell apoptosis of different cell lines
2012
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps
2006
Calorie restriction effects on silencing and recombination at the yeast rDNA
2009
Population Pharmacokinetics and Pharmacodynamics of Meropenem in Pediatric Patients
2006
A sensitive assay of amoxicillin in mouse serum and broncho-alveolar lavage fluid by liquid–liquid extraction and reversed-phase HPLC
2005
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection
2005
Pharmacodynamic Assessment of Clarithromycin in a Murine Model of Pneumococcal Pneumonia
2002
Clinical drug‐drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P‐glycoprotein
2014
Proteome-wide profiling of activated transcription factors with a concatenated tandem array of transcription factor response elements
2013
Effects of genistein on cell cycle and apoptosis of two murine melanoma cell lines
2007
Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections
2007
Population Pharmacokinetic Analysis and Dosing Regimen Optimization of Meropenem in Adult Patients
2006
Sir2 Represses Endogenous Polymerase II Transcription Units in the Ribosomal DNA Nontranscribed Spacer
2006